Literature DB >> 14963163

Inflammatory cytokines inhibit Kaposi's sarcoma-associated herpesvirus lytic gene transcription in in vitro-infected endothelial cells.

Steven Milligan1, Mairi Robinson, Elizabeth O'Donnell, David J Blackbourn.   

Abstract

The response of Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) to inflammatory cytokine treatment of experimentally infected endothelial cells was investigated. The cytokines inhibited spontaneous KSHV lytic gene expression but not the level of infection. The data suggest that if inflammatory cytokines present in KS lesions contribute to KSHV pathogenesis, they do so in part by promoting latent KSHV infection of the endothelial cells.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14963163      PMCID： PMC369204          DOI： 10.1128/jvi.78.5.2591-2596.2004

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  38 in total

1.  A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant.

Authors:  J S Cannon; D Ciufo; A L Hawkins; C A Griffin; M J Borowitz; G S Hayward; R F Ambinder
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Induction of human herpesvirus-8 gene expression by recombinant interferon gamma.

Authors:  D J Blackbourn; S Fujimura; T Kutzkey; J A Levy
Journal:  AIDS       Date:  2000-01-07       Impact factor: 4.177

3.  Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

Authors:  C Parravicini; B Chandran; M Corbellino; E Berti; M Paulli; P S Moore; Y Chang
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression.

Authors:  S Sakakibara; K Ueda; J Chen; T Okuno; K Yamanishi
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication.

Authors:  J Chang; R Renne; D Dittmer; D Ganem
Journal:  Virology       Date:  2000-01-05       Impact factor: 3.616

6.  Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells.

Authors:  M Mercader; B Taddeo; J R Panella; B Chandran; B J Nickoloff; K E Foreman
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

7.  Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus.

Authors:  W T Seaman; D Ye; R X Wang; E E Hale; M Weisse; E B Quinlivan
Journal:  Virology       Date:  1999-10-25       Impact factor: 3.616

Review 8.  Molecular virology of Kaposi's sarcoma-associated herpesvirus.

Authors:  P S Moore; Y Chang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

Review 9.  Biology of Kaposi's sarcoma.

Authors:  B Ensoli; C Sgadari; G Barillari; M C Sirianni; M Stürzl; P Monini
Journal:  Eur J Cancer       Date:  2001-07       Impact factor: 9.162

10.  The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells.

Authors:  S A Radkov; P Kellam; C Boshoff
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440
View more
  17 in total

1.  Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1.

Authors:  Ossie F Dyson; Christopher M Traylen; Shaw M Akula
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

2.  Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3.

Authors:  L M Butler; H C Jeffery; R L Wheat; H M Long; P C Rae; G B Nash; D J Blackbourn
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.

Authors:  Ruoyun Gao; Tingting Li; Brandon Tan; Suzane Ramos da Silva; Jae U Jung; Pinghui Feng; Shou-Jiang Gao
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

4.  The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis.

Authors:  Neelam Sharma-Walia; Karthic Chandran; Kinjan Patel; Mohanan Valiya Veettil; Alexandru Marginean
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

5.  Kaposi's Sarcoma-Associated Herpesvirus Reduces Cellular Myeloid Differentiation Primary-Response Gene 88 (MyD88) Expression via Modulation of Its RNA.

Authors:  Amy Lingel; Erica Ehlers; Qianli Wang; Mingxia Cao; Charles Wood; Rongtuan Lin; Luwen Zhang
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

6.  Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.

Authors:  Patrick A Carroll; Heidi L Kenerson; Raymond S Yeung; Michael Lagunoff
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

7.  Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.

Authors:  Yi Zeng; Xunhai Zhang; Zan Huang; Lin Cheng; Shuihong Yao; Di Qin; Xiuying Chen; Qiao Tang; Zhigang Lv; Ling Zhang; Chun Lu
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

8.  Suppression of antigen-specific T cell responses by the Kaposi's sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue, CD200.

Authors:  Karen Misstear; Simon A Chanas; S A Rahim Rezaee; Rachel Colman; Laura L Quinn; Heather M Long; Oliver Goodyear; Janet M Lord; Andrew D Hislop; David J Blackbourn
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

9.  Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion.

Authors:  Neelam Sharma-Walia; Arun George Paul; Virginie Bottero; Sathish Sadagopan; Mohanan Valiya Veettil; Nagaraj Kerur; Bala Chandran
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

10.  Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.

Authors:  Duosha Hu; Victoria Wang; Min Yang; Shahed Abdullah; David A Davis; Thomas S Uldrick; Mark N Polizzotto; Ravindra P Veeranna; Stefania Pittaluga; Giovanna Tosato; Robert Yarchoan
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.